ClinicalTrials.Veeva

Menu

Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population (COVIDAMBUCMA1)

D

Direction Centrale du Service de Santé des Armées

Status

Completed

Conditions

SARS-CoV2 Infection
Covid19

Treatments

Other: Questionnaires COVID-
Other: Questionnaires COVID+

Study type

Observational

Funder types

Other

Identifiers

NCT04893070
2021-A01038-33 (Other Identifier)
2020-COVID19-38

Details and patient eligibility

About

In April 2020, a meta-analysis on the long-term sequelae of respiratory syndromes related to seasonal coronaviruses (SARS and MERS) showed a significant alteration in quality of life, with in particular a decrease in physical and emotional capacities and a deterioration of social life. An improvement of the quality of life is evidenced after 6 months but without reaching the level usually observed in healthy people. The impact of SARS-CoV-2 infection on quality of life can be explained by the persistence of pleomorphic symptoms in the medium to long term. In the military population, the majority of SARS-CoV-2 cases present minor to moderate forms of the disease. Military personnel have living conditions that differ from those of the general population, in particular because of their geographic mobility, which may be responsible for isolation from the family. This isolation can be regular (we speak of "geographical celibacy" when the soldier is posted in a geographical area far from the family unit) and/or occasional, during missions on the national territory or outside. This singularity justifies a study on the impact of SARS-CoV-2 (COVID-19) infection on the quality of life in this specific population.

Enrollment

173 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Military personnel
  • COVID+: diagnosed with COVID-19 and managed in ambulatory care since March 14th, 2020
  • COVID-: not having been infected with SARS-CoV-2

Exclusion criteria

  • Hospitalized for COVID-19
  • Having received a treatment against COVID-19 (other than paracetamol)

Trial design

173 participants in 2 patient groups

COVID+
Description:
Questionnaires on COVID-19 symptomatology and quality of life
Treatment:
Other: Questionnaires COVID+
COVID-
Description:
Questionnaires on quality of life
Treatment:
Other: Questionnaires COVID-

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems